Supreme Court ruling on "reverse payments" complicates patent litigation settlements.

{
  "signal_id": "7ab9434e-e5b6-47a0-b182-23b4ec476415",
  "signal_type": "sec-10q",
  "signal_subtype": "litigationMaterial",
  "detected_at": "2026-05-05T08:48:21.389+00:00",
  "company": {
    "name": "Incyte",
    "domain": "incyte.com"
  },
  "data": {
    "detail": "A recent Supreme Court ruling creates uncertainty and difficulty in settling patent litigation with generic drug companies. This could lead to increased legal costs and a higher risk of earlier-than-expected generic competition for Incyte's products.",
    "summary": "Supreme Court ruling on \"reverse payments\" complicates patent litigation settlements.",
    "excerpts": "The Court rejected the “scope of the patent” test and ruled that settlements involving “reverse payments” from brand-name drug companies to generic drug companies should be analyzed under the rule of reason. This ruling may create uncertainty and make it more difficult to settle patent litigation if a company seeking to manufacture a generic version of one of our products challenges the patents covering that product prior to the expiration date of those patents.",
    "relevance": 0.7,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/879169/000087916926000026/incy-20260331.htm",
    "filing_date": "2026-04-28",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Legal tech opportunity",
    "signal_category": "risk",
    "regions_mentioned": [
      "United States"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/7ab9434e-e5b6-47a0-b182-23b4ec476415 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"incyte.com","limit":20}'